Sen. Franken, Hamburg discuss device industry's concerns

Sen. Al Franken (D-MN) shared the medical device industry's concerns with regulators this week. He met with FDA Commissioner Margaret Hamburg as federal regulators are considering more than 70 changes to the 510(k) pre-market review process for low- and moderate-risk devices. Devicemakers say some changes are needed to simplify the process, but they're worried about the FDA's proposals to strengthen an expedited review process that they say has a strong safety record. "During our meeting on Thursday, the FDA Commissioner committed to working with me, as a member of the Senate committee that oversees the FDA, to address the concerns of Minnesota's medical device community," Franken said in a statement. Article | Story

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.